SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Pharmos(PARS)
PARS 2.700+13.6%Jan 21 4:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: NeuroInvestment who wrote (1398)10/13/1998 10:35:00 AM
From: Richard Huth   of 1491
 
Thank you again for your posting. As a subscriber of BioCentury and NeuroInvestment I see both as very reliable sources. In this case I tend to follow NeuroInvestment's view.

But the article in BioCentury will have some influence and it reflects the worries I heard from other sides. A good death rate is easy to translate to investors. Data published by PARS will only be understood by very informed investors. Other will tend to stay aside, with negative results to stock price - as to see the last days.

In my opinion the development of Lotamex and Alrex sales will be the key for any positive trend for the next few month. What investors prefer right now is earnings, not hope.

Generally bullish we will have to keep this in mind; and perhaps see deeper prices ahead.

Richard
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News